最初不服从降脂药物:一个系统的文献综述
Catherine E Cooke1, Teisha Robertson2
1Department of Practice, Sciences and Health Outcomes Research, University of Maryland School of Pharmacy, 20 N. Pine Street, Office S446, Baltimore, Maryland, MD, 21201, USA. cCooke@rx.umaryland.edu.
BMC primary care
|August 5, 2024
概括
最初的药物不服药 (IMN) 影响到五分之一的患者处方降脂药. 这种不坚持可以导致更糟糕的心血管结果,突出需要有效的干预措施.
科学领域:
- 心血管药理学心血管药理学
- 医疗保健服务研究 医疗服务研究
- 公共卫生 公共卫生
背景情况:
- 对降脂药物的初始药物不坚持 (IMN) 损害了心血管健康.
- 了解IMN对于改善患者的治疗结果和药物有效性至关重要.
研究的目的:
- 总结有关IMN与美国降脂药物的流行,因素,后果和解决方案的证据.
- 为了识别与IMN相关的患者和处方者特征.
- 审查与IMN有关的报告的干预措施和临床结果.
主要方法:
- 在PubMed和谷歌学者 (2010-2021) 的系统文献搜索.
- 在美国成年人群中,将IMN纳入降脂药物的研究.
- 排除非英语,非成年,非美国人群和较弱的研究设计.
主要成果:
- IMN的发病率在10-18.2%的患者和1.4-43.8%的处方之间.
- 相关因素包括西班牙裔种族,黑人种族,较低的并发病率得分和初级保健处方.
- 患者的原因包括对生活方式改变的偏好和副作用的担忧;干预显示出混合的结果.
结论:
- 很大一部分患者没有获得新处方的降脂药物.
- 关于IMN的临床后果的数据有限.
- 需要进一步的研究来评估结果,并制定具有成本效益的战略来解决IMN.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
610
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
610
Assessment of the Cardiovascular System I: Subjective Data
293
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
293
Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
Factors Influencing Drug Absorption: Presystemic Elimination
199
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
199
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Overview of Lipid Metabolism
1.2K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.2K


